Cerebral Small Vessel Disease

Cerebral small vessel disease (SVD) refers to a heterogeneous group of pathologies affecting the small penetrating arteries, arterioles, capillaries, and small veins of the brain. SVD is the substrate of lacunar infarction, the most common cause of vascular cognitive impairment, the second most important cause of stroke after large artery disease, and a major contributor to dementia overall. The radiologic phenotype — lacunes, white matter hyperintensities, microbleeds, perivascular spaces, microinfarcts — reflects the underlying pathology of small vessel injury. This page covers the pathology, vascular biology, and clinical manifestations of cerebral SVD.

The Spectrum of SVD

SVD is not one disease but a family of conditions that share a final common pathway of small vessel damage:

  • Arteriolosclerosis (lipohyalinosis): the dominant sporadic form; associated with hypertension, diabetes, aging.
  • Cerebral amyloid angiopathy (see separate page).
  • CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy): NOTCH3 mutation.
  • CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy): HTRA1 mutation.
  • Mitochondrial SVD: MELAS and other mitochondrial syndromes affecting small vessels.
  • Vasculitic SVD: primary CNS angiitis, secondary vasculitis.
  • Fabry disease: alpha-galactosidase A deficiency; lysosomal storage in vessel walls.
  • Hereditary endotheliopathies: HERNS (hereditary endotheliopathy with retinopathy, nephropathy, stroke).
  • Sneddon syndrome: livedo reticularis + ischemic strokes + antiphospholipid antibodies.

Arteriolosclerosis / Lipohyalinosis

The dominant pathology of sporadic SVD:

  • Affected vessels: penetrating arterioles 40-200 μm in diameter, supplying basal ganglia, thalamus, brainstem, deep white matter.
  • Lipohyalinosis: lipid and hyaline material deposit in vessel wall, replacing normal smooth muscle and elastica.
  • Hyaline arteriolosclerosis: glassy thickening, narrowed lumen.
  • Fibrinoid necrosis: in severe cases.
  • Charcot-Bouchard microaneurysms: small outpouchings; source of hypertensive ICH.
  • Microatheroma: at branching points of the parent vessel; can occlude perforator origins.

Risk Factors

  • Hypertension (most important).
  • Diabetes mellitus.
  • Smoking.
  • Hyperlipidemia.
  • Age.
  • Sleep apnea.

Pathologic Phenotype of SVD

Lacunar Infarction

Small (< 1.5 cm) deep infarcts in territory of single penetrating vessel. Acute pathology mirrors larger infarcts (red neurons, edema, macrophage infiltration). Chronic state: small fluid-filled cavity = lacune.

White Matter Hyperintensities (WMH) / Leukoaraiosis

Diffuse white matter rarefaction visible as T2/FLAIR hyperintensity. Pathology:

  • Loss of myelin (LFB pallor).
  • Axonal damage (Bielschowsky).
  • Reactive gliosis.
  • Dilated perivascular spaces.
  • Microinfarcts and microbleeds.
  • Arteriolosclerosis of supplying vessels.

WMH is graded by the Fazekas scale (0-3 in periventricular and deep white matter) and is associated with cognitive decline and gait disturbance.

Cerebral Microbleeds

Small (under 5 mm) hemosiderin deposits on SWI/GRE. Deep distribution (basal ganglia, thalamus, pons) suggests hypertensive SVD; lobar distribution suggests CAA.

Cortical Microinfarcts

Microscopic (often < 1 mm) cortical infarcts visible on histology. Cumulatively contribute to cognitive decline. Often invisible or barely visible on MRI.

Dilated Perivascular Spaces (Virchow-Robin Spaces)

Enlarged CSF-filled spaces around penetrating vessels. Severe enlargement reflects SVD; in basal ganglia and centrum semiovale common patterns. May reflect impaired glymphatic clearance.

CADASIL

Most common monogenic cause of SVD. Autosomal dominant; NOTCH3 mutations (chromosome 19p13). Distinctive features:

  • Onset: 30-50s.
  • Clinical: migraine with aura (often the first manifestation) → recurrent lacunar strokes → progressive cognitive decline → eventually dementia. Mood disorder common.
  • MRI: extensive white matter hyperintensities, especially anterior temporal pole (highly characteristic) and external capsule. Lacunes, microbleeds.
  • Pathology: granular osmiophilic material (GOM) in vessel walls of small to medium arteries (detected on EM); NOTCH3 protein accumulation in vessel walls (IHC). Affects systemic vessels, not just CNS (skin biopsy can be diagnostic).
  • Diagnosis: genetic testing for NOTCH3 mutations; skin biopsy for GOM on EM.
  • Treatment: vascular risk factor control; no disease-modifying therapy.

CARASIL

Rare autosomal recessive; HTRA1 mutations. Similar SVD pattern to CADASIL plus alopecia and lumbar spondylosis. Distinguishing features:

  • Earlier onset (20-30s).
  • Spinal and skin features.
  • HTRA1 mutation on genetics.

Mitochondrial SVD (MELAS and related)

MELAS (mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes) and related syndromes affect small vessels:

  • Strokes that do not respect vascular territories.
  • Cortical and subcortical lesions, often posterior.
  • Lactic acid elevation.
  • Other systemic features: hearing loss, cardiomyopathy, diabetes.
  • Mitochondrial DNA mutation (commonly m.3243A>G in MT-TL1).
  • Muscle biopsy: ragged-red fibers.

Vasculitic SVD

Inflammatory destruction of small vessels — separate page in this section. Important to recognize because it is treatable.

Clinical Syndromes of SVD

Lacunar Syndromes

Classical patterns: pure motor, pure sensory, ataxic hemiparesis, dysarthria-clumsy hand, sensorimotor. See Localization section for clinical detail.

Subcortical Vascular Cognitive Impairment

Slowly progressive cognitive decline with predominant executive dysfunction, slowed processing, mood changes — reflecting cumulative SVD load. MRI shows multiple lacunes + confluent WMH + atrophy.

Vascular Parkinsonism (Lower Body Parkinsonism)

Gait apraxia, magnetic gait, postural instability with relatively preserved upper extremity function. Poor L-dopa response. From extensive subcortical SVD.

Pseudobulbar Palsy

Bilateral corticobulbar interruption from cumulative deep infarcts. Explosive dysarthria, dysphagia, emotional incontinence.

Hypertensive ICH

From Charcot-Bouchard microaneurysm rupture in the deep penetrators. Putamen most common.

Imaging Markers of SVD

STRIVE-2 (2023) update of standardized criteria for SVD imaging features:

  • Recent small subcortical infarct: acute lacunar infarct on DWI.
  • Lacune: chronic cavitated infarct, 3-15 mm.
  • White matter hyperintensity (WMH): T2/FLAIR.
  • Perivascular spaces (PVS): enlarged CSF spaces.
  • Cerebral microbleed (CMB): small hemosiderin deposit on SWI/GRE.
  • Brain atrophy: global or regional.
  • Cortical superficial siderosis: in CAA-predominant SVD.
  • Microinfarcts: tiny cortical infarcts.

Composite SVD scores (Charidimou and Wardlaw) integrate these features for prognostication.

Management Principles

  • BP control (most important — target individualized).
  • Antiplatelet for secondary prevention after lacunar stroke.
  • SPS3 trial: dual antiplatelet NOT recommended long-term for lacunar stroke.
  • Statin.
  • Diabetes management.
  • Smoking cessation.
  • Sleep apnea evaluation.
  • Avoid anticoagulation if CAA-predominant.
  • Cognitive rehabilitation, supportive care.

🔍 Did You Know?

The anterior temporal pole white matter hyperintensity in CADASIL is one of the most clinically useful single radiographic findings in neurology. While many causes of white matter disease produce diffuse periventricular and deep white matter changes, the involvement of the anterior temporal pole — which is normally well-preserved on T2 even in extensive aging or hypertensive SVD — is highly suggestive of CADASIL. The pattern is described as having ≥ 90% sensitivity and specificity for CADASIL in selected populations. Combined with external capsule involvement and a family history of stroke or dementia, this single MRI finding can prompt genetic testing for NOTCH3 mutations without an extensive prior workup. The disease was identified and characterized by Joutel and Tournier-Lasserve in the 1990s — they observed clusters of families with autosomal dominant subcortical strokes and migraines and traced it to NOTCH3 on chromosome 19. CADASIL is a paradigm of genetic SVD and serves as both a clinical entity in its own right and a window into the mechanism of small vessel disease in general — NOTCH3 signaling is important for smooth muscle development and vessel integrity. The recognition that a single specific imaging finding can identify a hereditary disease changed how the workup of young patients with strokes and white matter disease is approached. Always ask about family history and look at the anterior temporal poles.

Pitfalls and Pearls

  • SVD is heterogeneous: arteriolosclerotic (hypertensive), CAA, CADASIL, CARASIL, mitochondrial, vasculitic.
  • Hypertensive SVD: lipohyalinosis of small penetrators; Charcot-Bouchard microaneurysms; deep distribution.
  • CADASIL: autosomal dominant; NOTCH3; migraine + lacunar strokes + dementia; anterior temporal pole WMH; GOM on EM.
  • CARASIL: autosomal recessive; HTRA1; + alopecia + spondylosis.
  • MELAS: strokes not respecting vascular territories; lactic acidosis; ragged-red fibers on muscle biopsy.
  • Lacunar syndromes: pure motor, pure sensory, ataxic hemiparesis, dysarthria-clumsy hand, sensorimotor.
  • WMH + lacunes + cortical atrophy: subcortical vascular cognitive impairment.
  • Vascular parkinsonism: lower body parkinsonism; poor L-dopa response.
  • SPS3: long-term dual antiplatelet not beneficial for lacunar stroke secondary prevention.
  • BP control is the central prevention.
  • STRIVE-2: standardized SVD MRI features for research and clinical assessment.
  • Anterior temporal pole WMH + family history of stroke/migraine → CADASIL.
  • GOM (granular osmiophilic material) in CADASIL: skin biopsy on EM diagnostic.
  • Fabry disease: alpha-galactosidase deficiency; lysosomal accumulation in vessel walls; treatable.

References

  1. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483-497.
  2. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701.
  3. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707-710.
  4. Hara K, Shiga A, Fukutake T, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009;360(17):1729-1739.
  5. Duering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease — advances since 2013. Lancet Neurol. 2023;22(7):602-618.
  6. Charidimou A, Schmitt A, Wilson D, et al. The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): development and assessment of reliability. J Neurol Sci. 2017;372:178-183.